Evidence check: Menopause Check in the context of Langlebigkeit

The query asks for an evidence check on a 'Menopause Check' in the context of longevity. The provided context lacks any specific product or study on menopause testing. Menopause is a natural transition, not a disease. Genetic tests (e.g., for hormone receptor variants) or biomarkers (FSH, estradiol) cannot reliably predict timing or symptoms, nor directly influence longevity. Evidence for genetic predictors of menopause is weak (GWAS with small effect sizes). Hormone replacement therapy (HRT) has risk-benefit considerations but no clear life-extension effect. A 'Menopause Check' as a DNA test is currently marketing, not evidence-based medicine. Be cautious of overblown claims. For longevity, lifestyle factors (diet, exercise, stress management) are far more impactful. Cardiovascular risk factors (Lp(a), cholesterol) from the lipid context are relevant postmenopause, but not a menopause check per se. Conclusion: evidence grade 'marketing/unclear'. No validated sources in context.